On-Demand Video Panel Discussion

Share

Program Content

Activities

  • MRD in ALL
    Measurable Residual Disease in ALL: Proof of the Principle Transforming Care for Patients With Hematologic Malignancies
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 01, 2018

    Expires: November 08, 2019

Faculty

cover img faculity

Elias Jabbour, MD

Assistant Professor
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Joseph D. Khoury, MD

Professor
Department of Hematology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Aaron C. Logan, MD, PhD

Associate Professor
Division of Hematology and Blood and Marrow Transplantation
University of California, San Francisco
San Francisco, California

Provided by

ProCE Banner

Supporters

Adaptive Biotechnologies

Amgen, Inc.

Partners

GRACE

ProCE Banner